Carlos Castańo-Milla

ORCID: 0000-0003-4309-0352
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Microscopic Colitis
  • Inflammatory Bowel Disease
  • Gallbladder and Bile Duct Disorders
  • Pediatric Hepatobiliary Diseases and Treatments
  • Esophageal and GI Pathology
  • Biliary and Gastrointestinal Fistulas
  • Pancreatitis Pathology and Treatment
  • Celiac Disease Research and Management
  • Diagnosis and treatment of tuberculosis
  • Anorectal Disease Treatments and Outcomes
  • Dysphagia Assessment and Management
  • Hidradenitis Suppurativa and Treatments
  • Folate and B Vitamins Research
  • Congenital Diaphragmatic Hernia Studies
  • Foreign Body Medical Cases
  • Viral gastroenteritis research and epidemiology
  • Minerals Flotation and Separation Techniques
  • Tracheal and airway disorders
  • Gastroesophageal reflux and treatments
  • Gastrointestinal Tumor Research and Treatment
  • Acute Lymphoblastic Leukemia research
  • Liver Disease Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Abdominal vascular conditions and treatments
  • Pregnancy and Medication Impact

Hospital Universitario Rey Juan Carlos
2016-2024

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
2019

Universidad Autónoma de Madrid
2019

Hospital Universitario de La Princesa
2011-2014

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
2014

Centro de Investigación Biomédica en Red
2012

María José Casanova María Chaparro Valle García–Sánchez Óscar Nantes E Leo and 78 more M Rojas-Feria Aranzazu Jauregui-Amezaga Santiago García‐López José María Huguet Federico Argüelles‐Arias Marta Aicart Ignacio Marín‐Jiménez María Gómez–García Fernándo Muñoz María Esteve Luís Bujanda Xavier Cortés Joan Toscá J R Pineda Míriam Mañosa J Llaó Jordi Guardiola Isabel Pérez‐Martínez Clara Muñoz Yago González‐Lama Joaquín Hinojosa J.M. Vázquez Pilar Martínez-Montiel G E Rodríguez Ramón Pajares Mariana Fe García-Sepulcre Álvaro Hernández-Martínez J L Pérez-Calle Belén Beltrán David Busquets Laura Ramos Fernando Bermejo Jesús Barrio Manuel Barreiro‐de Acosta O Roncedo Xavier Calvet Daniel Hervías Fernando Gomollón Mercedes Domínguez-Antonaya G Alcaín Beatriz Sicilia Carmelo Dueñas Castell Ana Gutiérrez Rufo Humberto Lorente-Poyatos M.A. Domı́nguez Sam Khorrami Carlos Taxonera Aurelio Rodríguez Ángel Ponferrada Manuel Van Domselaar María Luisa Arias-Rivera Olga Merino Esmeralda Gracián-Castro José Miguel Marrero María Dolores Martín‐Arranz Belén Botella Luís Fernández-Salazar David Monfort Verónica Opio Antonio García‐Herola M Menacho Ramírez-de P la Piscina Daniel Ceballos Pedro Almela Mercè Navarro-Llavat Virginia Robles ANAHI VEGA-LOPEZ Irene Moraleja M T Novella Carlos Castańo-Milla Alba Sánchez‐Torres J M Benítez Cristina Rodríguez Luisa de Castro Elena Azaola Eugeni Domènech E. García‐Planella Javier P. Gisbert

The aims of this study were to assess the risk relapse after discontinuation anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory bowel disease (IBD), identify factors associated relapse, and evaluate overcome retreatment same anti-TNF those who relapsed.This was a retrospective, observational, multicenter study. IBD had been treated anti-TNFs whom these discontinued clinical remission achieved included.A total 1,055 included. incidence rate 19% 17% per patient-year...

10.1038/ajg.2016.569 article EN The American Journal of Gastroenterology 2016-12-13
María Chaparro Ana Garre Andrea Núñez Ortiz M T Diz-Lois Palomares Cristina Rodríguez and 95 more Sabino Riestra Milagros Vela J M Benítez Estela Fernández Salgado Eugenia Sánchez Rodríguez Vicent Hernández R Ferreiro-Iglesias Ángel Ponferrada Díaz Jesús Barrio José María Huguet Beatriz Sicilia María Dolores Martín‐Arranz Xavier Calvet Daniel Ginard Inmaculada Alonso-Abreu Luís Fernández-Salazar Pilar Varela Trastoy Montserrat Rivero Isabel Vera-Mendoza Pablo Vega Pablo Navarro Mónica Sierra José Luis Cabriada Mariam Aguas Raquel Vicente Mercè Navarro-Llavat Ana Echarri Fernando Gomollón Elena Guerra del Río Concepción Piñero María José Casanova Kateřina Špičáková Jone Ortiz de Zárate Emilio Torrella Cortés Ana Gutiérrez Horacio Alonso‐Galán Álvaro Hernández-Martínez José Miguel Marrero Rufo Lorente Poyatos Margalida Calafat Lidia Martí Romero Pilar Robledo Orencio Bosch Nuria Jiménez María Esteve José María Duque Ana Fuentes Coronel Manuela Josefa Sampedro Eva Sesé Abizanda Belén Herreros Martínez Liliana Pozzati Hipólito Fernández Rosáenz Belén Crespo Suarez Pilar López Serrano Alfredo J. Lucendo Margarita Muñoz Vicente Fernando Bermejo José Ramírez Palanca Margarita Menacho Amalia Carmona Raquel Camargo Sandra Torrá Alsina Nuria Maroto Juan Nerín de la Puerta Elena Castro Ignacio Marín‐Jiménez Belén Botella Amparo Sapiña Noelia Cruz José Luis Fernández Forcelledo Abdel Bouhmidi Carlos Castańo-Milla Verónica Opio Isabel Nicolás Marcos Kutz A. Abraldes Bechiarelli Jordi Gordillo Yolanda Ber Yolanda Torres Domínguez M. Novella Durán Silvia Rodríguez Mondéjar Francisco J. Martínez-Cerezo Lilyan Kolle M Sàbat César Ledezma Eduardo Iyo Óscar Roncero Rebeca Irisarri Laia Lluis Isabel Blázquez Gómez Eva Zapata María José Fernández Alcalá Cristina Martínez Pascual María Montealegre Laura Mata

(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe main epidemiological and clinical characteristics at diagnosis evolution disease, explore use drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 Spain were included followed-up for 1 year. (3) Results: We identified 3611 incident cases during 108 hospitals...

10.3390/jcm10132885 article EN Journal of Clinical Medicine 2021-06-29

Data regarding the effectiveness of adalimumab (ADA) in treatment perianal fistula patients with Crohn's disease (CD) naive to antitumor necrosis factor (TNF) therapy are scarce.: To assess ADA fistulas CD anti-TNF therapy.A retrospective multicenter study was designed. The Fistula Drainage Assessment Index used clinical response, and Van Assche Ng indexes classify radiologic response (magnetic resonance imaging).A total 46 (83% women, 83% complex fistula) were included. At 6 months, 72%...

10.1097/mcg.0000000000000169 article EN Journal of Clinical Gastroenterology 2014-06-26
Ana Vázquez Andrea Núñez Ortiz S Rubio María Teresa Diz-Lois Palomares Sabino Riestra and 95 more Horacio Alonso‐Galán E Fernández-Salgado R Ferreiro-Iglesias Milagros Vela Ángel Ponferrada Díaz Eugenia Sánchez Rodríguez Vicent Hernández Lara Arias García Jesús Barrio José María Huguet Daniel Ginard Montserrat Rivero Isabel Vera Mendoza Inmaculada Alonso-Abreu J M Benítez Mariam Aguas Iago Rodríguez‐Lago Xavier Calvet Luís Fernández-Salazar Ana Echarri M Arroyo Mercè Navarro-Llavat Pablo Vega Mónica Sierra Elena Guerra del Río Raquel Vicente María José Casanova Pablo Navarro Jone Ortiz de Zárate Pilar Varela Trastoy Kateřina Špičáková Ana Gutiérrez María Dolores Martín‐Arranz Concepción Piñero Álvaro Hernández-Martínez Emilio Torrella Cortés José Miguel Marrero R H Lorente Poyatos Lidia Martí Romero Orencio Bosch José María Duque Montserrat Aceituno H Fernández Belén Crespo Suarez Ana Fuentes Coronel Liliana Pozzati Pilar Robledo Eva Sesé Abizanda Belén Herreros Martínez Nuria Jiménez Pilar López Serrano Manuela Josefa Sampedro Fernando Bermejo Alfredo J. Lucendo Margarita Muñoz Vicente Margarita Menacho José Joaquín Ramírez Palanca Raquel Camargo Amalia Carmona Sandra Torrá Alsina Margalida Calafat José Luis Fernández Forcelledo Juan Nerín de la Puerta Isabel Nicolás Verónica Opio Yolanda Ber Abdel Bouhmidi A. Abraldes Bechiarelli Carlos Castańo-Milla Noelia Cruz Jordi Gordillo Amparo Sapiña Alina López Silvia Rodríguez Mondéjar María Teresa Novella Durán Belén Botella Marcos Kutz Lilyan Kolle Ignacio Marín‐Jiménez Francisco J. Martínez-Cerezo Rebeca Irisarri Eduardo Iyo Óscar Roncero M Sàbat Yolanda Torres Domínguez César Ledezma Eva María Zapata María José Fernández Alcalá Laia Lluis Cristina Martínez Pascual Isabel Blázquez Gómez Luis Hernández Laura Mata Ana Monrobel Alejandro Hernández-Camba

10.1016/s0210-5705(25)00148-7 article ES Gastroenterología y Hepatología 2025-01-01

Microscopic colitis is a form of chronic and recurrent inflammatory bowel disease characterized by non-bloody, watery diarrhea, macroscopically normal colonic mucosa, characteristic histopathological findings. Some drugs have been described as triggers inflammation in predisposed individuals, while others may exacerbate microscopic that evolves on its own. We present the case patient diagnosed with active relation to taking fluoxetine at high doses.

10.17235/reed.2024.10336/2024 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2024-01-01

Abstract Background Obesity rates in patients with IBD reach up to 40%. Several authors suggest that obese have worse response treatments. The aim of the study is determine whether body mass index (BMI) influences biological therapies IBD. Secondly, other risk factors will be analyzed, and different treatments compared. Methods A retrospective cohort on biologic drugs under treatment between February 2013 September 2022 presented. Patients were recruited from consultation a tertiary center...

10.1093/ecco-jcc/jjad212.0915 article EN Journal of Crohn s and Colitis 2024-01-01

A 68-year-old male presented to the Emergency Department with a one-month history of intermittent epigastrium pain. Laboratory tests revealed leukocytosis and elevated lipase (4129 UI/l), normal liver function, so he was admitted for its first episode acute pancreatitis. Abdominal ultrasound showed steatosis, without cholelithiasis or bile duct dilatation. thoraco-abdominal computed tomography performed, revealing pedunculated gastric polyp in lesser curvature measuring 64x38mm no evidence...

10.17235/reed.2024.10299/2024 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2024-01-01

Abstract Text An 86-year-old female with acute lithiasic cholecystitis unfit for surgery underwent EUS-guided gallbladder drainage (EUS-GBD) using a lumen apposing-metal stent (LAMS). Two months later she was readmitted new episode of cholecystitis. Computed tomography scan showed obstruction the LAMS and two large lithiasis, one them adjacent to cystic duct. During procedure we identified that embedded so repermeabilized it, performed direct cholecystoscopy standard gastroscope through...

10.1055/s-0044-1783674 article EN Endoscopy 2024-04-01

Abstract Text A 74-year-old female underwent EUS-guided cholecystogastrostomy using a lumen apposing metal stent for distal biliary obstruction secondary to unresectable pancreatic cancer. After five months she was admitted acute cholangitis. Computed tomography scan showed of the cholecystogastric fistula. Endoscopic repermeabilization cholecystoenteric fistula and gallbladder cleansing performed. Subsequently, we attempted complete drainage by transcystic rendezvous ERCP, as well...

10.1055/s-0044-1783443 article EN Endoscopy 2024-04-01

Abstract Text A 51-year-old female with liver cirrhosis and recurrent alcohol-induced pancreatitis was admitted for abdominal pain vomiting. An MRI confirmed a large pancreatic pseudocyst. EUS-guided drainage using lumen-apposing metal stent (LAMS) performed. Due to LAMS complete misdeployment during the procedure, second placed, retrieval inside pseudocyst delayed. After seven days, removed endoscopically.

10.1055/s-0044-1783284 article EN Endoscopy 2024-04-01

Abstract Text A 71-year-old female was admitted for painless jaundice. Computed tomography scan showed resectable-borderline pancreatic head tumor with dilation of the biliary tree. Biliary drainage by ERCP failed. So, we performed an EUS-guided choledochoduodenostomy (EUS-CDS) using a lumen-apposing metal stent electrocautery-enhanced delivery system (EC-LAMS). During procedure there LAMS misdeployment choledochoduodenal perforation. This adverse event treated gallbladder (EUS-GBD)...

10.1055/s-0044-1783267 article EN Endoscopy 2024-04-01

Bacterial peritonitis with loculated ascites in patients liver cirrhosis can be a therapeutic challenge. We present the case of patient undergoing pre-transplant evaluation, diagnosed bacterial secondary to urgent surgical intervention Imaging studies identified markedly ascites, poor response despite broad-spectrum antibiotic therapy. The use intraabdominal urokinase was safe and effective adjuvant treatment for resolution this complication.

10.17235/reed.2024.10661/2024 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2024-01-01

P365 Effectiveness of adalimumab in the treatment perianal fistulas patients with Crohn’s disease naive to anti-TNF: A multicenter study C. Castano-Milla1 *, M. Chaparro1, Saro Gismera2, Barreiro-de Acosta3, A.M. Garcia-Albert4, L. Bujanda5, M.D. Martin Arranz6, D. Carpio7, F. Munoz8, N. Mancenido Marcos9, E. Garcia-Planella10, Piqueras11, X. Calvet Calvo12, J.L. Cabriada13, B. Botella14, J.P. Gisbert1. 1Hospital De La Princesa, IP, Gastroenterology and CIBEREHD, Madrid, Spain, 2Hospital...

10.1016/s1873-9946(12)60384-5 article ES Journal of Crohn s and Colitis 2012-02-01

Atrial fibrillation is a major cause of death and disability due to stroke. Vitamin K antagonist drugs are effective for prevention, but they have narrow therapeutic range multiple pharmacological interactions. In recent years, new alternatives been searched minimize complications. The main objective evaluate the risk gastrointestinal bleeding in anticoagulated patients compare classic treatment with anticoagulants.We conducted retrospective cohort study determine treated...

10.1111/jgh.15547 article EN Journal of Gastroenterology and Hepatology 2021-05-12

We present the case of a 67-year-old female with recent cholecystectomy for symptomatic cholelithiasis. She was admitted to our hospital right upper quadrant abdominal pain and vomiting. Laboratory analysis revealed hyperbilirubinemia cytolysis cholestasis. Abdominal ultrasound choledocholithiasis 8 mm. Endoscopic retrograde cholangiopancreatography (ERCP) scheduled. With duodenoscope, after reduction maneuver from second duodenal portion face major papilla, perforation approximately 18 mm...

10.17235/reed.2023.9339/2022 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2023-01-01

10.1016/s0210-5705(23)00127-9 article ES Gastroenterología y Hepatología 2023-03-01
Coming Soon ...